US FDA Nods X4 Pharmaceutical's Therapy For Immunodeficiency Disease

The US FDA has approved its treatment for patients over 12 with a rare genetic immunodeficiency disease, per X4 Pharmaceuticals. X4's mavorixafor, to be sold under the brand name Xolremdi, is the primary treatment to get U.S. endorsement...

Manipal Hospitals Acquires Majority Stake in Medica Synergie

Manipal Hospitals, a leading multispeciality hospital, added that it is gaining an 87% stake in Kolkata-based clinic chain Medica Synergie in a contract that industry sources said is expected to be worth an expected ₹1,400 crore...

Yokogawa Helps to Revolutionize the Field of Single-Cell Lipidomics

Yokogawa Electric Corporation’s latest single-cell analysis solution, the Single Cellome™ System SS2000, has been featured in an article published in the high-profile journal Analytical Chemistry

PharmaLink and Recall Results Ink Pact To Improve Drug Safety

PharmaLink Inc., a pharmaceutical reverse distribution firm, declared a strategic agreement with Review Results, which aims to upgrade drug well-being and review productivity in the pharmaceutical industry. The innovative agreement uses...

IIT Bombay's Latest Facility to Bridge the Gap between Real-World and Laboratory Activities

The state-of-the-art 10X GMP facility at IIT Bombay will expedite the translation of academic research into innovative medical products, bridging the gap between laboratory discoveries and real-world impact. The 10X GMP Facility at IIT Bombay is t...

Glenmark's Latest Generic Drug Approval Results in Soaring Share Prices

Glenmark Pharma's share price on both the NSE and BSE soared to a 52-week high following the company's announcement of receiving approval from the US health regulator to market a generic version of an anti-inflammatory drug in the American market....

© 2024 India Pharma Outlook. All Rights Reserved.